Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
dc.contributor.author | Gasperetti, Tracy | |
dc.contributor.author | Miller, Tessa | |
dc.contributor.author | Gao, Feng | |
dc.contributor.author | Narayanan, Jayashree | |
dc.contributor.author | Jacobs, Elizabeth R. | |
dc.contributor.author | Szabo, Aniko | |
dc.contributor.author | Cox, George N. | |
dc.contributor.author | Orschell, Christie M. | |
dc.contributor.author | Fish, Brian L. | |
dc.contributor.author | Medhora, Meetha | |
dc.contributor.department | Medicine, School of Medicine | en_US |
dc.date.accessioned | 2023-03-10T14:55:20Z | |
dc.date.available | 2023-03-10T14:55:20Z | |
dc.date.issued | 2021-08-25 | |
dc.description.abstract | [This corrects the article DOI: 10.3389/fphar.2021.634477.]. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Gasperetti T, Miller T, Gao F, et al. Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes. Front Pharmacol. 2021;12:741485. Published 2021 Aug 25. doi:10.3389/fphar.2021.741485 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/31807 | |
dc.language.iso | en_US | en_US |
dc.publisher | Frontiers Media | en_US |
dc.relation.isversionof | 10.3389/fphar.2021.741485 | en_US |
dc.relation.journal | Frontiers in Pharmacology | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | * |
dc.source | PMC | en_US |
dc.subject | Corrections | en_US |
dc.subject | Polypharmacy | en_US |
dc.subject | Acute radiation syndrome | en_US |
dc.subject | Delayed effects of acute radiation exposure | en_US |
dc.subject | Mitigation | en_US |
dc.subject | Hematopoietic growth factor | en_US |
dc.subject | Lisinopril | en_US |
dc.subject | Supportive care | en_US |
dc.subject | Radiation pneumonitis | en_US |
dc.title | Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes | en_US |
dc.type | Article | en_US |